Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Topics:
Radiation Oncology
•
Sarcoma
What dose-fractionation and clinical target volume do you use when treating tenosynovial giant cell tumor (TGCT), historically known as pigmented villonodular synovitis (PVNS), of the knee?
Answer from: Radiation Oncologist at Community Practice
4500 cGy at 180cGy/fx.
Sign in or Register to read more
14297
Related Questions
How do you sequence treatment for a patient following R2 resection of a large extremity leiomyosarcoma who has small lung nodules concerning for metastatic disease, but not yet biopsy proven?
Do you offer neoadjuvant radiation therapy for oral cavity sarcoma?
Would you recommend radiation therapy for an adult patient with rhabdomyosarcoma (embryonal) of the upper extremity s/p amputation with multiple lymph node involvement and ENE on pathology?
What dose fractionation would you consider for adjuvant reirradiation for locally recurrent epithelioid sarcoma?
What technique and dose would you use for a paravertebral leiomyosarcoma met deposit at T9-T10 s/p resection with a positive margin?
How would you approach patients with primary cardiac sarcomas for adjuvant systemic treatment?
What post-operative dose do you use to treat pigmented villonodular synovitis?
For unresectable radiation induced angiosarcoma, what dose and fractionation would you use?
What adjuvant therapy would you recommend for a patient with a sarcomatoid carcinoma of the submandibular gland after R1 resection?
What techniques and dose constraints do you utilize to limit lower extremity neuropathy when providing post op radiation following soft tissue sarcoma resection?